These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma. Wójcicka A; Czetwertyńska M; Świerniak M; Długosińska J; Maciąg M; Czajka A; Dymecka K; Kubiak A; Kot A; Płoski R; de la Chapelle A; Jażdżewski K Genes Chromosomes Cancer; 2014 Jun; 53(6):516-23. PubMed ID: 24599715 [TBL] [Abstract][Full Text] [Related]
9. Germ-line mutations in Zhao Y; Yu T; Sun J; Wang F; Cheng C; He S; Chen L; Xie D; Fu L; Guan X; Yan A; Li Y; Miao G; Zhu X Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326253 [TBL] [Abstract][Full Text] [Related]
10. A Truncating Germline Mutation of He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178 [No Abstract] [Full Text] [Related]
12. Germline mutations in a DNA repair pathway are associated with familial colorectal cancer. Xu P; Sun D; Gao Y; Jiang Y; Zhong M; Zhao G; Chen J; Wang Z; Liu Q; Hong J; Chen H; Chen YX; Fang JY JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34549727 [TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid cancer in a patient with germline CHEK2 mutation: A case report. da Silva Santos T; Tkachenko N; Couto de Carvalho A Ann Endocrinol (Paris); 2021 Dec; 82(6):624-626. PubMed ID: 34555328 [No Abstract] [Full Text] [Related]
14. Germline Mutations in Familial Papillary Thyroid Cancer. Sarquis M; Moraes DC; Bastos-Rodrigues L; Azevedo PG; Ramos AV; Reis FV; Dande PV; Paim I; Friedman E; De Marco L Endocr Pathol; 2020 Mar; 31(1):14-20. PubMed ID: 32034658 [TBL] [Abstract][Full Text] [Related]
16. The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients. Wagener R; Walter C; Auer F; Alzoubi D; Hauer J; Fischer U; Varghese J; Dugas M; Borkhardt A; Brozou T Int J Cancer; 2023 Apr; 152(7):1388-1398. PubMed ID: 36468172 [TBL] [Abstract][Full Text] [Related]
17. Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls. Kern B; Coppin L; Romanet P; Crépin M; Szuster I; Renaud F; Leteurtre E; Frénois F; Wemeau JL; Carnaille B; Cardot-Bauters C; Do Cao C; Pigny P Eur J Med Genet; 2017 Mar; 60(3):178-184. PubMed ID: 28089742 [TBL] [Abstract][Full Text] [Related]
18. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci. Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407 [TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease. Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992 [TBL] [Abstract][Full Text] [Related]